Phosphotyrosine phosphatase-activity in membranes from endometrial carcinoma

T Furui1, A Imai, H Takagi

  • 1GIFU UNIV,SCH MED,DEPT OBSTET & GYNECOL,GIFU 500,JAPAN.

Oncology Reports
|May 21, 2011
PubMed

Insights

Phosphotyrosine phosphatase (PTPase) activity was measured in normal and cancerous endometrial tissues. PTPase activity was found to be similar across proliferative, secretory, and cancerous endometria, suggesting a role in counterbalancing cell growth.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Gynecologic Oncology

Background:

  • Phosphotyrosine phosphatases (PTPases) regulate cellular processes by dephosphorylating tyrosine residues on proteins.
  • Tyrosine phosphorylation, mediated by tyrosine kinases, is crucial for cell growth and differentiation.
  • Dysregulation of PTPase activity is implicated in various cancers, including endometrial carcinoma.

Purpose of the Study:

  • To determine and characterize phosphotyrosine phosphatase (PTPase) activity in normal and cancerous endometrial tissues.
  • To investigate the potential role of PTPase activity in the context of endometrial carcinoma.

Main Methods:

  • PTPase activity was quantified using a spectrophotometric assay with the synthetic substrate p-nitrophenyl.
  • Enzyme activity was assessed in both normal (proliferative and secretory phase) and cancerous endometrial tissues.
  • The subcellular localization of PTPase activity was investigated.

Main Results:

  • Over 90% of the measured PTPase activity was found to be associated with cellular particulates.
  • PTPase activity levels were comparable across proliferative endometria, secretory endometria, and endometrial carcinomas.
  • This indicates a consistent presence of PTPase activity in both healthy and malignant endometrial tissue.

Conclusions:

  • The study demonstrates the presence of phosphotyrosine phosphatase (PTPase) activity in endometrial carcinoma.
  • This PTPase activity appears to counterbalance the growth-promoting effects of tyrosine kinases in endometrial cancer.
  • Further research into PTPase function may reveal therapeutic targets for endometrial cancer.